Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bonesupport Holding ABCHIX:BONEXS 70 Market Cap is kr14,315 Mil as of Aug. 23, 2026. GuruFocus rates CHIX:BONEXS with a GF Score™ of 70/100 and a GF Value™ of kr470.36 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 859 Medical Devices & Instruments companies, Bonesupport Holding AB ranks better than 83.82% on this metric.
Bonesupport Holding AB's quarterly market cap
increased
from Dec. 2025 (kr12,457 Mil) to Mar. 2026 (kr12,517 Mil) and
increased
from Mar. 2026 (kr12,517 Mil) to Jun. 2026 (kr15,036 Mil).
Bonesupport Holding AB's annual market cap
increased
from Dec. 2023 (kr9,563 Mil) to Dec. 2024 (kr21,483 Mil) but then
declined
from Dec. 2024 (kr21,483 Mil) to Dec. 2025 (kr12,457 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Bonesupport Holding AB's Enterprise Value for Today is kr13,891 Mil.
Bonesupport Holding AB (CHIX:BONEXs) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:BONEXS vs ISRG, BDX, MDLN: Market Cap Comparison
For the Medical Instruments & Supplies subindustry, Bonesupport Holding AB's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bonesupport Holding AB Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Bonesupport Holding AB's Market Cap distribution charts can be found below:
* The bar in red indicates where Bonesupport Holding AB's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Bonesupport Holding AB's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bonesupport Holding AB (CHIX:BONEXS) has a Market Cap of kr14,315 Mil as of Aug. 23, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Bonesupport Holding AB and its competitors. According to the industry distribution chart, Bonesupport Holding AB ranks #139 out of 859 companies in the Medical Devices & Instruments industry, placing it in the top 16.2%.
Is Bonesupport Holding AB's Market Cap too high?
Bonesupport Holding AB's current Market Cap is kr14,315 Mil. Based on the distribution chart, Bonesupport Holding AB ranks #139 out of 859 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Bonesupport Holding AB has a GF Score™ of 70/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bonesupport Holding AB's Market Cap compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Bonesupport Holding AB ranks #139 out of 859 companies for Market Cap. This places Bonesupport Holding AB in the top 16% of its industry — outperforming the majority of peers. The industry median Market Cap is 121.64. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 121.64, based on 859 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Bonesupport Holding AB and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 121.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bonesupport Holding AB's current Market Cap is kr14,315 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bonesupport Holding AB stock overvalued right now?
Based on GuruFocus' analysis, Bonesupport Holding AB (CHIX:BONEXS) is currently considered Significantly Undervalued. The stock's GF Value™ is kr470.36, compared to a current price of kr219.70 — trading 53.3% below its estimated fair value. The current Market Cap is kr14,315 Mil. Bonesupport Holding AB's overall GF Score™ is 70/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Bonesupport Holding AB (CHIX:BONEXS), the current Market Cap is kr14,315 Mil as of Aug. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bonesupport Holding AB (CHIX:BONEXS) Overvalued in 2026?
Based on GuruFocus' analysis, Bonesupport Holding AB stock appears to be undervalued.
The current stock price of kr219.70 is trading 53.3% below its estimated GF Value™ of kr470.36.
GuruFocus considers Bonesupport Holding AB to be Significantly Undervalued.
Key valuation signals for CHIX:BONEXS:
Market Cap: kr14,315 Mil
GF Value™: kr470.36 vs. price of kr219.70 (53.3% below fair value)
No single metric tells the full story. See the CHIX:BONEXS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bonesupport Holding AB is a fast-growing ortho-biologics company that focuses on the treatment of bone disorders. The Company develops and commercializes injectable bio-ceramic bone graft substitutes based on its CERAMENT platform, which remodels to bone and can release pharmaceuticals to promote healing. The products of the company focus on trauma, revision arthroplasty (replacement of joint prostheses), chronic osteomyelitis (bone infection), and foot and ankle surgery. The Group manages and monitors operations in two operating segments: United States and Europe & Rest of the World (EUROW).
70GF Score
Get the complete analysis for CHIX:BONEXS
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:BONEXS has been successfully added to your 
